Keyphrases
Abatacept
100%
Alemtuzumab
100%
Autoimmune Enteropathy
100%
Cellular Compartments
20%
Clinical Course
40%
Crypt Apoptosis
20%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
20%
Dilated Cardiomyopathy
20%
Endoscopic Biopsy
20%
Graft-versus-host Disease (GvHD)
20%
Heart Transplant
20%
Heart Transplant Recipients
100%
Heart Transplantation
40%
Hematochezia
20%
Hypergammaglobulinemia
20%
Immune Dysregulation
40%
Immune Parameters
20%
Immune Regulation
20%
JAK Inhibitors
20%
Medical History
20%
Memory Phenotype
20%
Neonatal Thymectomy
20%
Pediatric Heart Transplant
100%
Remission
40%
T Cell Lymphopenia
20%
T Cells
20%
TCR Repertoire
20%
Thymectomy
20%
Treatment Strategy
20%
Working Diagnosis
20%
Medicine and Dentistry
Abatacept
100%
Alemtuzumab
100%
Cell Compartment
16%
Dilated Cardiomyopathy
16%
Disease
33%
Disease Course
33%
Endoscopic Biopsy
16%
Enteropathy
100%
Graft Versus Host Reaction
16%
Heart Graft
100%
Heart Transplantation
33%
Hypergammaglobulinemia
16%
Immune Dysregulation
33%
Immunity
33%
Immunomodulation
16%
Infancy
16%
Janus Kinase Inhibitor
16%
Lymphocytopenia
16%
Medical History
16%
Pediatrics
100%
Programmed Cell Death
16%
Rectal Bleeding
16%
T Cell
33%
T Cell Receptor
16%
Thymectomy
33%
Immunology and Microbiology
Abatacept
100%
Alemtuzumab
100%
Autoimmune Enteropathy
100%
Graft-Versus-Host Disease
16%
Heart Transplantation
33%
Hypergammaglobulinemia
16%
Immune Dysregulation
33%
Immunity
33%
Immunomodulation
16%
Infancy
16%
Lymphocytopenia
16%
Programmed Cell Death
16%
T Cell
33%
T Cell Receptor
16%
Pharmacology, Toxicology and Pharmaceutical Science
Abatacept
100%
Alemtuzumab
100%
Congestive Cardiomyopathy
16%
Disease Course
33%
Enteropathy
100%
Graft Versus Host Reaction
16%
Hypergammaglobulinemia
16%
Immune Dysregulation
33%
Janus Kinase Inhibitor
16%
Lymphocytopenia
16%
Medical History
16%
Rectum Hemorrhage
16%
Remission
33%